European evidence-based consensus on the diagnosis and management of Crohn's disease

Hanauer, S. B.; Sandborn, W. J.
February 2007
Gut;Feb2007, Vol. 56 Issue 2, p161
Academic Journal
The article discusses the evidence-based consensus on the management and diagnosis of Crohn's disease in Europe. A consensus was established by The European Crohn's and Colitis Organization (ECCO) on the promotion of views, clinical trials and specialist training in inflammatory bowel diseases. The methods established by the consensus is aligned with practice guidelines from the U.S. The author reflects that the consensus is an outstanding effort to assimilate and treatment of the disease.


Related Articles

  • Risk Factors for Perianal Crohn's Disease: The Role of Genotype, Phenotype, and Ethnicity. Karban, Amir; Itay, Maza; Davidovich, Ofir; Leshinsky-Silver, Esther; Kimmel, Gad; Fidder, Herma; Shamir, Ron; Waterman, Matti; Eliakim, Rami; Levine, Arie // American Journal of Gastroenterology;Aug2007, Vol. 102 Issue 8, p1702 

    OBJECTIVES: Perianal disease (PD) is a frequent complication of Crohn's disease (CD). The lack of association between PD and development of intestinal penetrating disease may suggest that PD is a distinct phenotype with specific genetic or clinical risk factors. This study was undertaken to...

  • BIOLOGICS IN INFLAMMATORY BOWEL DISEASE: HOW MUCH PROGRESS HAVE WE MADE? Sandborn, W. J.; Faubion, W. A. // Gut;Sep2004, Vol. 53 Issue 9, p1366 

    The article focuses on the progress made in the treatment of inflammatory bowel disease with biologic therapies, concentrating primarily on the tumor necrosis factor (TNF) inhibitors infliximab, etanercept, adalirnumab, CDP87O, CDP571 and onercept, and on the selective adhesion molecule...

  • Answer to case of the month #74. McTavish, Jeffrey D.; Zalev, Arthur // Canadian Association of Radiologists Journal;Feb2000, Vol. 51 Issue 1, p52 

    Presents a clinical case of a man with Crohn's disease. Case report; Radiological findings; Pathophysiology and diagnosis of the disease condition; Presenting signs and symptoms.

  • Inflammatory Bowel Disorders.  // Current Medical Literature: Gastroenterology;2011, Vol. 30 Issue 1, p21 

    The article discusses various research that explored the different aspects of inflammatory bowel disorders. One of the studies dealt with the changes in surgical resection rates and medical treatments for Crohn's disease. Another research focused on the association of pre-operative management...

  • Targeting leukocyte migration and adhesion in Crohn's disease and ulcerative colitis. Thomas, Saskia; Baumgart, Daniel // Inflammopharmacology;Feb2012, Vol. 20 Issue 1, p1 

    Crohn's disease and ulcerative colitis are two chronic inflammatory bowel diseases. Current biologic therapies are limited to blocking tumor necrosis factor alpha. However, some patients are primary non-responders, experience a loss of response, intolerance or side effects defining the urgent...

  • Perception of eye contact in video teleconsultation. Tam, Tony; Cafazzo, Joseph A.; Seto, Emily; Salenieks, Mary Ellen; Rossos, Peter G. // Journal of Telemedicine & Telecare;Jan2007, Vol. 13 Issue 1, p35 

    During patient consultations by videoconferencing, clinicians often sit as close as 1 m from the videoconferencing units, creating a significant eye gaze angle (i.e. the angle between the eye and the camera, and the eye and the centre of the display). Eye gaze angle may adversely affect the...

  • New therapeutic approach in inflammatory bowel disease. PAPA, A.; MOCCI, G.; SCALDAFERRI, F.; BONIZZI, M.; FELICE, C.; ANDRISANI, G.; GASBARRINI, A. // European Review for Medical & Pharmacological Sciences;Jan2009 Supplement, Vol. 13 Issue S-1, p33 

    In the last decade, biologic agents, in particular infliximab and adalimumab, have deeply changed the therapeutic armamentarium of inflammatory bowel disease (IBD). However, these drugs have a number of contraindications and side-effects that physicians should know so to avoid and eventually...

  • Utilization of Health Care Resources by Individuals with Inflammatory Bowel Disease in the United States: A Profile of Time Since Diagnosis. Longobardi, Teresa; Jacobs, Phillip; Bernstein, Charles N. // American Journal of Gastroenterology;Apr2004, Vol. 99 Issue 4, p650 

    BACKGROUND: There are no cost studies of inflammatory bowel disease (IBD) that describe its impact on resource utilization or treatment costs over long periods of time. Our aim was to determine if there are observable trends in health-care resource utilization by adults with IBD depending on...

  • Acute Idiopathic Pancreatitis Complicating Active Crohn's Disease: Favorable Response to Infliximab Treatment. Triantafillidis, John K.; Cheracakis, Petros; Hereti, Irini A.; Argyros, Nikolaos; Karra, Evangelia // American Journal of Gastroenterology;Nov2000, Vol. 95 Issue 11, p3334 

    Reports on the case of a male patient with Crohn's disease involving concurrently the small and large bowel, which developed idiopathic acute pancreatitis during a severe flare-up of his underlying inflammatory bowel disease. Medical history of the patient; Response of the patient to infliximab...


Read the Article


Sign out of this library

Other Topics